INTERNATIONAL PATENT: HANMI PHARM. CO., LTD., 한미약품 주식회사 FILES APPLICATION FOR "COMBINATION PREPARATION CONTAINING EZETIMIBE, ROSUVASTATIN AND EMPAGLIFLOZIN, WITH IMPROVED DRUG COMPLIANCE"

GENEVA, Nov. 18 -- HANMI PHARM. CO., LTD. (214, Muha-ro, Paltan-myeonHwaseong-siGyeonggi-do 18536), 한미약품 주식회사 (경기도화성시팔탄면 무하로 214) filed a patent application (PCT/KR2025/006173) for "COMBINATION PREPARATION CONTAINING EZETIMIBE, ROSUVASTATIN AND EMPAGLIFLOZIN, WITH IMPROVED DRUG COMPLIANCE" on May 08, 2025. With publication no. WO/2025/234781, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Invento...